Literature DB >> 30135013

Long non-coding RNA TTN-AS1 promotes cell growth and metastasis in cervical cancer via miR-573/E2F3.

Ping Chen1, Rui Wang1, Qingfen Yue2, Mengmeng Hao3.   

Abstract

Long non-coding RNAs (lncRNAs) are a crucial member of non-coding RNA family, and increasing evidence demonstrates that lncRNAs participate in the initiation and progression of cancers. Our study aimed to explore the role of lncRNA TTN-AS1 in cervical cancer (CC) development. In the present study, our results showed that TTN-AS1 was substantially increased in CC tissues and cell lines, high expression of TTN-AS1 was correlated with advanced FIGO stage, poor differentiation, lymph node metastasis, and poor overall survival of CC patients. Function assays showed that TTN-AS1 inhibition decreased the proliferation and invasion of CC cells both in vitro and in vivo. Mechanistically, we revealed that TTN-AS1 could positively modulate E2F3 expression via sponging miR-573 in CC cells. Together, our study revealed that lncRNA TTN-AS1 was involved in the progression of CC cells by regulation of miR-573-E2F3 axis, which offered a new insight into the treatment strategies of CC.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cervical cancer; E2F3; lncRNA TTN-AS1; miR-573

Mesh:

Substances:

Year:  2018        PMID: 30135013     DOI: 10.1016/j.bbrc.2018.08.077

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  30 in total

1.  miR-573 suppresses pancreatic cancer cell proliferation, migration, and invasion through targeting TSPAN1.

Authors:  Lei Wang; Peng Gao; Ping Yuan; Pengcheng Zhou; Haowen Fan; Xida Lin; Xiaoyu Yuan; Mingyan Zhu; Xiangjun Fan; Yuhua Lu; Zhiwei Wang
Journal:  Strahlenther Onkol       Date:  2020-12-15       Impact factor: 3.621

Review 2.  LncRNA-miRNA-mRNA regulatory axes in endometrial cancer: a comprehensive overview.

Authors:  Abhishek Shetty; Thejaswini Venkatesh; Shama Prasada Kabbekodu; Rie Tsutsumi; Padmanaban S Suresh
Journal:  Arch Gynecol Obstet       Date:  2022-02-18       Impact factor: 2.493

3.  LncRNA TTN-AS1 Promotes Progression of Non-Small Cell Lung Cancer via Regulating miR-491-5p/ZNF503 Axis.

Authors:  Guanbin Qi; Lei Li
Journal:  Onco Targets Ther       Date:  2020-07-01       Impact factor: 4.147

4.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

5.  MicroRNA 573 Rescues Endothelial Dysfunction during Dengue Virus Infection under PPARγ Regulation.

Authors:  Shefali Banerjee; Chin Wei Xin; Justin Jang Hann Chu
Journal:  J Virol       Date:  2022-03-23       Impact factor: 6.549

6.  LncRNA TTN‑AS1 promotes endometrial cancer by sponging miR‑376a‑3p.

Authors:  Longde Shen; Yinyin Wu; Ailu Li; Lichun Li; Longyuan Shen; Qiuxia Jiang; Qiuxia Li; Zhifen Wu; Liji Yu; Xiaohong Zhang
Journal:  Oncol Rep       Date:  2020-07-15       Impact factor: 3.906

7.  lncRNA PCNAP1 predicts poor prognosis in breast cancer and promotes cancer metastasis via miR‑340‑5p‑dependent upregulation of SOX4.

Authors:  Yang Yu; Yaning He; Yingbo Shao; Qi Chen; Hui Liu
Journal:  Oncol Rep       Date:  2020-07-20       Impact factor: 3.906

8.  LncRNA TTN-AS1 promotes migration, invasion, and epithelial mesenchymal transition of lung adenocarcinoma via sponging miR-142-5p to regulate CDK5.

Authors:  Yunlong Jia; Yuqing Duan; Tianxu Liu; Xuexiao Wang; Wei Lv; Mengjie Wang; Jiali Wang; Lihua Liu
Journal:  Cell Death Dis       Date:  2019-07-30       Impact factor: 8.469

9.  LncRNA TTN-AS1 acts as a tumor promoter in gallbladder carcinoma by regulating miR-107/HMGA1 axis.

Authors:  Zhaoxia Lin; Yaosheng Li; Rongfeng Shao; Yuqing Hu; Han Gao
Journal:  World J Surg Oncol       Date:  2021-06-05       Impact factor: 2.754

10.  Metabolism-Relevant Molecular Classification Identifies Tumor Immune Microenvironment Characterization and Immunotherapeutic Effect in Cervical Cancer.

Authors:  Luyi Li; Hui Gao; Danhan Wang; Hao Jiang; Hongzhu Wang; Jiajian Yu; Xin Jiang; Changjiang Huang
Journal:  Front Mol Biosci       Date:  2021-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.